Analyze Diet

Efficacy of ivermectin (22,23-dihydroavermectin B1) against gastrointestinal parasites in ponies.

Abstract: The controlled test method was used to evaluate the antiparasitic efficacy of IM inoculated 22,23-dihydroavermectin B1 (ivermectin) against gastrointestinal parasites of horses (ponies). Parasite infections were naturally acquired in southern Louisiana. Dose levels of the drug tested were 0.2 mg/kg, 0.3 mg/kg, and 0.5 mg/kg. Ivermectin at all dose levels tested had an efficacy greater than 97% (P less than 0.05) against Gasterophilus intestinalis larvae, Trichostrongylus axei, Oxyuris equi larvae, Strongylus vulgaris, S edentatus, 15 species of small strongyles, and small strongyle larvae. Ponies were less uniformly infected with Habronema sp larvae, G nasalis larvae, Parascaris equorum, O equi adults, Anoplocephala perfoliata, S equinus, and 11 small strongyle species, and statistical analysis was not possible to do. However, observations indicate that the drug was also highly effective against these species. There were no gross or clinical reactions observed in treated animals. Dissections of the injection sites revealed spindle-shaped lesions, 3 to 5 cm long, in a few ponies in all treatment groups, including those given the placebo injection.
Publication Date: 1980-11-01 PubMed ID: 6894221
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Comparative Study
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study explored the effectiveness of the drug ivermectin in treating gastrointestinal parasites in ponies. High effectiveness was found across all doses tested, with no negative side effects observed in the treated animals.

Methodology

  • The research employed a controlled test method to investigate the efficacy of ivermectin, also known as 22,23-dihydroavermectin B1, in combating gastrointestinal parasites in horses, specifically, ponies.
  • Parasite infections in the ponies studied were naturally acquired and prevalently found in southern Louisiana.
  • The researchers tested the drug at three different dose levels: 0.2 mg/kg, 0.3 mg/kg, and 0.5 mg/kg.

Findings

  • Ivermectin showed high efficiency at all dosage levels; it scored greater than 97% effective against a variety of parasitic species including Gasterophilus intestinalis larvae, Trichostrongylus axei, Oxyuris equi larvae, Strongylus vulgaris, S edentatus, 15 species of small strongyles and small strongyle larvae.
  • Ponies were less consistently infected with several other types of parasites, namely Habronema sp larvae, G nasalis larvae, Parascaris equorum, O equi adults, Anoplocephala perfoliata, S equinus, and 11 small strongyle species. Although statistical analysis was not feasible due to the inconsistencies in infection rates of these parasites, observational data seemed to also support the high efficacy of ivermectin against these species.
  • Throughout the testing procedure, no gross or clinical reactions were observed in the treated animals, indicating the drug did not cause noticeable harm or discomfort.
  • Examinations of the injection sites did reveal small, spindle-shaped lesions in a few ponies across all treatment groups, including those administered a placebo injection.

Conclusions

  • The study concludes that ivermectin is a highly efficient treatment for gastrointestinal parasites in ponies, evidenced by its high success rate across varying dosage levels.
  • The absence of negative side effects in the treated ponies amplifies the potential for ivermectin to be an effective treatment in combating parasites in horses.
  • However, the emergence of small lesions at the injection sites warrants further research to fully understand their cause and implications.

Cite This Article

APA
Klei TR, Torbert BJ. (1980). Efficacy of ivermectin (22,23-dihydroavermectin B1) against gastrointestinal parasites in ponies. Am J Vet Res, 41(11), 1747-1750.

Publication

ISSN: 0002-9645
NlmUniqueID: 0375011
Country: United States
Language: English
Volume: 41
Issue: 11
Pages: 1747-1750

Researcher Affiliations

Klei, T R
    Torbert, B J

      MeSH Terms

      • Animals
      • Anthelmintics / administration & dosage
      • Anthelmintics / therapeutic use
      • Diptera
      • Horse Diseases / drug therapy
      • Horses
      • Ivermectin
      • Lactones / administration & dosage
      • Lactones / therapeutic use
      • Nematode Infections / drug therapy
      • Nematode Infections / veterinary
      • Parasitic Diseases / drug therapy
      • Parasitic Diseases, Animal
      • Strongyle Infections, Equine / drug therapy

      Citations

      This article has been cited 5 times.
      1. Sauermann CW, Leathwick DM, Lieffering M, Nielsen MK. Climate change is likely to increase the development rate of anthelmintic resistance in equine cyathostomins in New Zealand.. Int J Parasitol Drugs Drug Resist 2020 Dec;14:73-79.
        doi: 10.1016/j.ijpddr.2020.09.001pubmed: 32992276google scholar: lookup
      2. Leathwick DM, Sauermann CW, Nielsen MK. Managing anthelmintic resistance in cyathostomin parasites: Investigating the benefits of refugia-based strategies.. Int J Parasitol Drugs Drug Resist 2019 Aug;10:118-124.
        doi: 10.1016/j.ijpddr.2019.08.008pubmed: 31491731google scholar: lookup
      3. Barragry TB. A review of the pharmacology and clinical uses of ivermectin.. Can Vet J 1987 Aug;28(8):512-7.
        pubmed: 17422843
      4. Lind EO, Kuzmina T, Uggla A, Waller PJ, Höglund J. A field study on the effect of some anthelmintics on cyathostomins of horses in sweden.. Vet Res Commun 2007 Jan;31(1):53-65.
        doi: 10.1007/s11259-006-3402-5pubmed: 17186406google scholar: lookup
      5. Slocombe JO, McCraw BM. Evaluation of ivermectin against later fourth-stage Strongylus vulgaris in ponies at two and five weeks after treatment.. Can J Comp Med 1984 Oct;48(4):343-8.
        pubmed: 6391639